Cetuximab plus radiotherapy for head and neck cancer

被引：0

作者：

Cengiz, M ^{[1
]}

Yildiz, F

Genc, M

机构：

[1] Univ Hacettepe, TR-06100 Ankara, Turkey

[2] Selcuk Univ, TR-42080 Konya, Turkey

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 354卷 / 20期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：2187 / 2187

页数：1

相关论文

共 2 条

[1] HYPERFRACTIONATION VERSUS CONVENTIONAL FRACTIONATION IN OROPHARYNGEAL CARCINOMA - FINAL ANALYSIS OF A RANDOMIZED TRIAL OF THE EORTC COOPERATIVE GROUP OF RADIOTHERAPY [J].

HORIOT, JC ;

LEFUR, R ;

NGUYEN, T ;

CHENAL, C ;

SCHRAUB, S ;

ALFONSI, S ;

GARDANI, G ;

VANDENBOGAERT, W ;

DANCZAK, S ;

BOLLA, M ;

VANGLABBEKE, M ;

DEPAUW, M .

RADIOTHERAPY AND ONCOLOGY, 1992, 25 (04) :231-241

[2] The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy [J].

Magné, N ;

Pivot, X ;

Bensadoun, RJ ;

Guardiola, E ;

Poissonnet, G ;

Dassonville, O ;

Francoual, M ;

Formento, JL ;

Demard, F ;

Schneider, M ;

Milano, G .

EUROPEAN JOURNAL OF CANCER, 2001, 37 (17) :2169-2177